Less radiation explored in multiple studies at San Antonio Breast Cancer Symposium, and National Cancer Institute writes next precision medicine chapter.

by Marci A. Landsmann

FDA announces investigation into CAR T-cell therapy, and precision therapies are not available for most cancer diagnoses.

by Kevin McLaughlin

Study finds association between vitamin D levels and risk for peripheral neuropathy, and new report highlights rising lung cancer survival.

by Thomas Celona

Sun exposure is an occupational hazard around the globe, and a dormant virus can cause immunotherapy complications.

by Eric Fitzsimmons

Recommendation suggests ongoing lung cancer screening for those with heavy smoking history even after quitting, and children with Down syndrome and leukemia face worse outcomes.

by Marci A. Landsmann

Living alone may increase the risk of cancer death, and cervical cancer study results called ‘remarkable.’

by Kevin McLaughlin

Immunotherapy drug approved as pre- and post-surgery treatment for non-small cell lung cancer, and bladder cancer patients who respond to chemotherapy and immunotherapy can forgo surgery.

by Thomas Celona

Rising prevalence of non-melanoma skin cancer leads to more deaths across the globe, and siblings of cancer patients struggle to ask for help.

by Eric Fitzsimmons

Minority groups less likely to receive palliative care, and radiation oncology meeting focuses on shorter radiation courses.

by Marci A. Landsmann

Cancer drug shortages affect pediatric care, and ‘power dynamics’ limit women’s access to cancer care globally.

by Kevin McLaughlin